抗血小板药物作用机制及应用

被引:3
作者
高珂
李凌
机构
[1] 郑州大学第一附属医院心内科
关键词
抗血小板药物; 联合治疗;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
摘要
阿司匹林作为传统的抗血小板药物,对心血管疾病的一级预防、二级预防有着极其重要的地位,可降低心血管事件的发病率及病死率,是心血管疾病治疗的"基石"。近年来新型抗血小板药物的研发及应用,可通过不同途径更有效抑制血小板聚集、血栓形成,有效地减少动脉粥样硬化性血管事件,进行血运重建治疗的患者,也可以降低术后心血管事件的发生率。
引用
收藏
页码:104 / 106
相关论文
共 20 条
  • [1] 心血管药理学[M]. 人民卫生出版社 , 陈修等主编, 2002
  • [2] GP IIb/IIIa受体拮抗剂在急性冠脉综合征的临床进展
    方哲
    金海
    周玉杰
    李艳芳
    李月平
    [J]. 吉林医学, 2007, (02) : 150 - 153
  • [3] Clarity about the use of clopidogrel in patients with acute cnronary syndromes and myocardial infarction. Doggrell SA. Expert Opinion on Pharmacotherapy . 2005
  • [4] Use of platelet glycoproteinⅡb/Ⅲa inhibitors in diabetics undergoing PCI fnr non-ST-segment elevation acute coronary syndromes:impact of clinical status and procedural characteristics. Bauer T,M (o|¨)llmann H,Weidinger F,et al. Clin Res Cardiol . 2010
  • [5] Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. M. Catalano,G. Born,R. Peto. Journal of Internal Medicine . 2007
  • [6] Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization[J] . David E. Winchester,Xuerong Wen,William D. Brearley,Ki E. Park,R. David Anderson,Anthony A. Bavry. &nbspJournal of the American College of Cardiology . 2011 (10)
  • [7] ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?[J] . Rouhl,Lodder. &nbspExpert Review of Neurotherapeutics . 2008 (11)
  • [8] Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)[J] . Stephen D. Wiviott,Elliott M. Antman,C. Michael Gibson,Gilles Montalescot,Jeffrey Riesmeyer,Govinda Weerakkody,Kenneth J. Winters,Jeffrey W. Warmke,Carolyn H. McCabe,Eugene Braunwald. &nbspAmerican Heart Journal .
  • [9] CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction
    Doggrell, SA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (10) : 1761 - 1764
  • [10] Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASS. Bertrand ME,Rupprecht HJ,Urban P,et al. Circulation . 2000